Indivior Pharmaceuticals, Inc. (INDV) Gross profit 2022–2025
Indivior Pharmaceuticals, Inc. (INDV) annual gross profit history from SEC filings — each fiscal year as reported.
$994.0MFY2025 · since FY2022: $749.0M → $994.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $994.0M | +3.9% |
| FY2024 | $957.0M | +4.1% |
| FY2023 | $919.0M | +22.7% |
| FY2022 | $749.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice